The Horizons Tracker

NOVEMBER 29, 2023

Numerous companies are now addressing market and regulatory demands by actively seeking to enhance the demographic diversity of their corporate boards. Moderna, a prominent pharmaceutical and biotechnology firm, adopted an unconventional approach utilizing RNA technology to develop one of the COVID-19 vaccines.

Diversity 111

Diversity Innovation Biotechnology Short-term 111

Strategy Driven

NOVEMBER 18, 2019

This increased the need for care items for the elderly and there are plenty of gaps in the market for the healthcare sector. There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in.

Health Care 66

Health Care Biotechnology Energy Insurance 66

Strategy Driven

MAY 12, 2021

According to Market Analysts, the Global 3D displays market is expected to grow by double digits with market size of over $100 billion in the next 5 years. Several display technologies including LED, OLED, and LCD serve this particular market. Video games are already a $100b+ market.

Technology 98

Technology Content Video Globalization 98

The Horizons Tracker

DECEMBER 30, 2019

Location has always been vital for startups, both in terms of providing ready access to human capital to help develop the startup’s proposition, but also to provide ready access to a local market to help develop momentum. This has prompted many of the fastest growing companies of our age to congregate in the same places.

Biotechnology 49

Biotechnology Human Capital Travel Entrepreneur 49

The Idolbuster

JANUARY 15, 2013

I heard a cautionary tale from “George” the former VP of marketing at a mid-sized biotechnology company about how a bogus forecast helped propagate a disaster. Marketing then back calculated the number of units, service contracts, and consumables that would need to be sold to make the forecast. (As

Biotechnology 41

Biotechnology Groupthink CFO Stress 41

HR Digest

MAY 14, 2022

The biotechnology company announced Gomez’s appointment as the new Moderna CFO on April 11. Moderna sales of the Covid-19 vaccine helped bolster its presence in the stock market. Moderna CFO Jorge Gomez had assumed the position just one day prior, almost a month after leaving a dental company. Moderna’s New CFO.

CFO 52

CFO Chief Financial Officer Due Diligence Biotechnology 52

Skip Prichard

JULY 22, 2019

Bezos’ approach works especially well when the innovation requires overcoming a lot of market/demand uncertainty (will people buy it?) Unfortunately, many of us have developed expertise in only one field (software engineering, information technology [IT], marketing, biotechnology, automobile manufacturing, the food industry, etc.

Innovation 83

Innovation Reputation Social Capital How To 83

Harvard Business Review

MAY 2, 2011

As multinational corporations pursue opportunities in emerging markets, they're bound to stumble if they overlook the developed economies, and vice versa. Nokia, for example, commanded market shares of 40% in China and 56% in India by 2008. Nokia, for example, commanded market shares of 40% in China and 56% in India by 2008.

Globalization 15

Globalization Marketing Venture Capitalist Biotechnology 15

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

OCTOBER 26, 2011

Their behavior displays promising parallels to the early days of the biotechnology industry. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive.

Energy 14

Energy Finance IPO Biotechnology 14

Harvard Business Review

APRIL 27, 2012

but the emerging markets boom has generally been more about catching up than exploiting cutting-edge technology.). The only exception was in the late 1990s, when excitement over how much the Internet was going to change everything spurred an investment bubble that briefly drove real growth.

Stephenson 20

Stephenson Innovation Biotechnology eBook 20

Harvard Business Review

MARCH 28, 2012

This means they're buying drugs that could be similar to others already on or coming soon to the market. No company should confuse the strategy of buying into a big market with buying innovation that will bring tomorrow's growth. The market reaction to all of this was mixed, but the trajectory was set for one way: higher.

Innovation 15

Innovation Company Biotechnology CFO 15

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology.

Competitive Advantage 16

Competitive Advantage Globalization Development Intellectual Capital 16

Harvard Business Review

JUNE 21, 2013

Given the forecasts of uncertain global economic growth, we might expect companies to hold off from hiring new employees and to limit whatever international hiring they do to emerging markets. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Asia into North America).

Telecommunications 13

Telecommunications Health Care Talent Management Biotechnology 13

Harvard Business Review

MARCH 13, 2012

And of course that's true — but the commodities market has been booming only in recent years, and the bank's track record is long and impressive. Is it possible that local funding could help bolster tourism in Florida, biotechnology in California, publishing in New York, and agriculture in Iowa?

Biotechnology 12

Biotechnology Real Estate Tourism Banking 12

Harvard Business Review

OCTOBER 1, 2014

But wait a minute – is starting more new businesses always a good thing?

Entrepreneur 15

Entrepreneur Biotechnology Real Estate Long-term 15

Harvard Business Review

MAY 7, 2018

She was on the legal compliance team at a fast-growing biotechnology company. Her role was to work with marketing to ensure that promotional campaigns and materials were in line with government guidelines. Karen had always been invited to key marketing meetings, but she noticed that more and more meetings were happening without her.

Restructuring 15

Restructuring How To Compliance Biotechnology 15

Harvard Business Review

JULY 11, 2018

However, young people are less common in other industries such as oil and gas or biotechnology, where the average age is closer to 47. Jeff Bezos and Amazon have moved far beyond selling books online, and Amazon’s future market cap growth rate was highest when Bezos was 45.

Succession 15

Succession IPO Entrepreneur Biotechnology 15

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. It is commonly believed that emerging market companies tap Western R&D talent in order to 'move up the value chain.'

Globalization 12

Globalization Innovation Decentralization Chemicals 12

Harvard Business Review

MARCH 11, 2014

Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants). In these markets if existing companies don’t rise to the innovation challenge, no one will.

Venture Capitalist 10

Venture Capitalist Innovation Company Supply Chain 10

Harvard Business Review

MARCH 17, 2014

An estimated 250 funds are actively raising capital in a market that the Global Impact Investing Network estimates at $25 billion. In impact investing, we need to find a way to place that same premium on social impact by valuing the public good being created – just like we do in early stage R&D in science, IT, health, and biotechnology.

Development 11

Development Microfinance Biotechnology Exit Strategy 11

Harvard Business Review

FEBRUARY 22, 2013

Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. Baldino moved aggressively to bring Provigil to market. Baldino sought to convince thought leaders of the therapeutic benefit, prove the drug worked, and then market it to the needy community. By 2010, sales exceeded $2B.

Products 9

Products Productivity Biotechnology IPO 9

Harvard Business Review

OCTOBER 16, 2013

Or Chipotle, $12 billion market value right now based in Denver. Under Armour, athletic-wear company based in Baltimore. Groupon in the social commerce space, based in Chicago. I think venture capitalists do play a role.

Venture Capitalist 14

Venture Capitalist Company Biotechnology Transportation 14

Harvard Business Review

MARCH 5, 2012

Thus, the decline of manufacturing is not completely a result of "natural" market forces. This tight connection between R&D, innovation, and production is present in sectors like biotechnology, advanced materials, and nanotechnology. By subsidizing other industries so generously, we have tilted the scales away from manufacturing.

Health Care 11

Health Care Biotechnology Industry Policies 11

Harvard Business Review

OCTOBER 22, 2013

In order to do this, your company needs a process to source radical ideas that can catapult your business to new heights, open up new markets, or bring in completely unfamiliar profit streams. But in today’s ever-connected world, finding radical ideas seems to be getting tougher for companies. Use Convergence Thinking.

Skills 11

Skills Power Six Sigma Disruptive Innovation 11

Harvard Business Review

JUNE 3, 2013

Is the problem that P&G produces outstanding specialists in marketing but not general managers who can run the business? pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Where was its leadership bench? What kind of signal did this choice send to P&G''s top managers?

Succession 9

Succession Telecommunications Biotechnology Real Estate 9

Harvard Business Review

JULY 16, 2013

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., banking & financial services, insurance, real estate); Health Care (e.g.,

Telecommunications 10

Telecommunications Health Care Biotechnology Real Estate 10

Harvard Business Review

MARCH 8, 2013

government is often portrayed as providing a safeguard against market failure. Elsewhere, I have called this role, which entails creating and shaping markets more than "fixing" them, " the entrepreneurial state.". In a business context, the U.S. government's risky investments have had for technology-based corporations.

Venture Capitalist 8

Venture Capitalist Biotechnology Fashion Technology 8

Harvard Business Review

AUGUST 17, 2015

There was a spike in the 2000s when Venezuela began to provide petroleum at deeply discounted market prices, and that peaked just before the 2008-09 financial crisis. It is probably the best, most well-trained workforce at the cheapest labor-market price that any international investor could find anywhere in the world.

Biotechnology 8

Biotechnology Human Capital Tourism Pharmaceuticals 8

Harvard Business Review

NOVEMBER 15, 2016

In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices. Witness the case of Uber, which has a market valuation exceeding $60 billion and is still a privately held company.

Drucker 8

Drucker Biotechnology Software Entrepreneur 8

Harvard Business Review

MAY 10, 2016

After all, if acquisitions pay off they can provide a transformational antidote to a slowing core market and declining margins. Gillette dominated the men’s shaving market with its Mach series of razors.

Strategy 8

Strategy Company Biotechnology Franchising 8

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long. The options are tangible.

Health Care 9

Health Care Pharmaceuticals Information Technology Supply Chain 9

Harvard Business Review

NOVEMBER 29, 2016

It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

FEBRUARY 16, 2016

If their projections turn out to be right, we should get ready for a bumpy road ahead, with market volatility and negative surprises. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Boards are clearly aligned with business leaders and executives on their outlooks for 2016.

Politics 8

Politics Telecommunications Policies Biotechnology 8

Harvard Business Review

JUNE 16, 2016

To understand the nature of the problem, let’s look at how penicillin was brought to market. Profit-driven companies, on the other hand, feel so much pressure to go to market that they often pass on ideas with vast potential. The Valley of Death.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

FEBRUARY 19, 2015

Or pay a freelance consultant to do market research? They “carved out time on nights and weekends” to do research and market analysis. ” Kate left her job at PerkinElmer in February 2014; the next month, she and her business partner started ORIGƷN, a Boston-based biotechnology company. Patch weak spots.

Project 8

Project Outsourcing Learning-by-Doing Career 8

Harvard Business Review

FEBRUARY 3, 2015

Uzzi and another colleague, Jarrett Spiro, also discovered that this pattern held across sectors as disparate as the Broadway mu­sical industry and biotechnology. Learn more about your market value. Be a guest speaker at a local or national event. Use it to build or strengthen your brand around a particular area of expertise.

How To 8

How To Diversity Letter Learning-by-Doing 8